On the other hand, anti-VEGF treatment reduced the tumor volume, and the combination with CAR-T cell therapy (anti-VEGF + CAR-T) caused further reduction in tumor volume in both experimental and simulated data (Fig. 3A GSC005). Here, VEGFA is linked to neoplasm.